Cryo Cell International (CCEL) Net Cash Flow Growth (3y) (2013 - 2026)
Cryo Cell International (CCEL) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 54.67% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | -88.93% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | -41.97% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 60.86% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | -70.77% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 38.26% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | -21.23% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | -38.79% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | - |
| 10 | Cryo Cell International | 32.09 Mn | 28.93 Mn | 6.10 Mn | 44.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 44.77% |
| Feb 28, 2026 | 40.60% |
| Nov 30, 2025 | 26.91% |
| Aug 31, 2025 | 2.03% |
| May 31, 2025 | -28.66% |
| Feb 28, 2025 | 61.92% |
| Nov 30, 2024 | -13.53% |
| Aug 31, 2024 | -3.20% |
| May 31, 2024 | 27.38% |
| Feb 29, 2024 | -29.53% |
| Nov 30, 2023 | -27.63% |
| Aug 31, 2023 | -20.07% |
| May 31, 2023 | -303.00% |
| Feb 28, 2023 | -29.59% |
| Nov 30, 2022 | -15.24% |
| Aug 31, 2022 | -48.30% |
| May 31, 2022 | 45.60% |
| Feb 28, 2022 | -99.23% |
| Nov 30, 2021 | 36.84% |
| Aug 31, 2021 | -35.64% |